Analgesia is particularly susceptible to placebo responses. Recent studies in humans have provided important insights into the neurobiology underlying placebo-induced analgesia. However, human studies provide incomplete mechanistic explanations of placebo analgesia because of limited capacity to use cellular, molecular, and genetic manipulations. To address this shortcoming, this article describes the development of a rat model of conditioned analgesia in an operant pain assay. Specifically, rats were conditioned to associate a placebo manipulation with the analgesic effect of 1 mg/kg morphine (subcutaneously) on facial thermal pain. We found that conditioned (placebo) responding bore 3 of the hallmarks of placebo-induced analgesia: (1) strong interanimal variability in the response, (2) suppression by the opiate antagonist naloxone (5 mg/kg subcutaneously), and (3) a positive predictive relationship between the unconditioned analgesic effect and the conditioned (placebo) effect. Because of the operant nature of the assay and the use of only a mild noxious thermal stimulus, we suggest that these results provide evidence of placebo-induced analgesia in a preclinical model that utilizes an affective behavioral end point. This finding may provide opportunities for invasive preclinical studies allowing greater understanding of placebo-induced analgesia, thus paving the way for avenues to harness its benefits. Ó
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Introduction
Placebo provided early preclinical evidence supporting this hypothesis, showing that a conditioned stimulus (i.e., placebo) paired with the amnesic agent scopolamine causes animals to perform poorly in a memory test. Certainly, when viewed in the context of classical conditioning, many examples of such placebo responses can be found throughout the fields of learning, memory, and addiction [1, 9, 12, 24, 28, 31, 49, 61] . However, remarkably few preclinical studies have focused on placebo-induced analgesia. Thus, we present here evidence of placebo-induced analgesia in a preclinical model.
As far as we are aware, there have been only 2 major preclinical studies of placebo-induced analgesia using animal models. Both studies used reflex-based pain assays and relatively high doses of opiate drugs [11, 29] . In the first, Bryant et al. showed that placebo induced analgesia in mice conditioned with the potent opiate fentanyl, measured using a hot plate [11] . In the second, Guo et al. showed that a cue paired with morphine (MOR) or aspirin elicited analgesic responses, also on a hot plate [29] .
Although these studies provide important foundations for further studies of placebo-induced analgesia, we reason that they are
